Longitudinal study of immunity to SARS‐CoV2 in ocrelizumab‐treated MS patients up to 2 years after COVID‐19 vaccination
Article in Annals of Clinical and Translational Neurology (May 2024)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Annals of Clinical and Translational Neurology (May 2024)
Article in Annals of the Russian academy of medical sciences (February 2024)
Preprint in medRxiv (January 2024)